Maravai LifeSciences
MRVI
MRVI
143 hedge funds and large institutions have $3.51B invested in Maravai LifeSciences in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.97% more ownership
Funds ownership: 100.82% → 101.79% (+0.97%)
31% less call options, than puts
Call options by funds: $2.29M | Put options by funds: $3.34M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
143
Holding in Top 10
3
Calls
$2.29M
Puts
$3.34M
Top Buyers
| 1 | +$142M | |
| 2 | +$142M | |
| 3 | +$60.9M | |
| 4 |
Morgan Stanley
New York
|
+$49.2M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$40.9M |
Top Sellers
| 1 | -$166M | |
| 2 | -$42.8M | |
| 3 | -$33.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$30.4M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$27.4M |